A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease
Clinical trial NCT06310967 · RECRUITING
Trial details
- NCT number
- NCT06310967
- Sponsor
- Intelligem Therapeutics Australia Pty Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-12
- Primary completion
- 2026-07-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.